Portal de Periódicos da CAPES

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

2013; Nature Portfolio; Volume: 19; Issue: 2 Linguagem: Inglês

10.1038/nm.3048

1546-170X

Andrew J. Souers, Joel D. Leverson, Erwin R. Boghaert, Scott Ackler, Nathaniel D. Catron, Jun Chen, Brian D. Dayton, Hong Ding, Sari H. Enschede, Wayne J. Fairbrother, David C.S. Huang, S.G. Hymowitz, Sha Jin, Seong Lin Khaw, Peter Kovar, Lloyd T. Lam, Jackie Lee, Heather Maecker, Kennan C. Marsh, Kylie D. Mason, Michael J. Mitten, Paul Nimmer, Anatol Oleksijew, Chang H. Park, Cheol‐Min Park, Darren C. Phillips, Andrew W. Roberts, Deepak Sampath, John F. Seymour, Morey L. Smith, Gerard M. Sullivan, Stephen K. Tahir, Chris Tse, Michael Wendt, Xiao Yu, John Xue, Haichao Zhang, Rod Humerickhouse, Saul H. Rosenberg, Steven W. Elmore,

Acute Lymphoblastic Leukemia research